- £77.60bn
- £92.78bn
- £32.67bn
REG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Transaction in Own Shares
AnnouncementREG - GSK PLC - Japan MHLW approves Arexvy for adults 18-49 AIR
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Collaboration with CTTQ for bepirovirsen
AnnouncementREG - GSK PLC - GSK - final tranche of share buyback programme
AnnouncementREG - GSK PLC - Result of AGM
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - Holding(s) in Company
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - 1st Quarter Results
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Bepirovirsen priority review US filing acceptance
AnnouncementREG - GSK PLC - Efimosfermin granted US/EU regulatory designations
AnnouncementREG - GSK PLC - TESARO update on AnaptysBio Inc. litigation
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
Announcement